Free Trial
ASX:AGN

Argenica Therapeutics (AGN) Stock Price, News & Analysis

About Argenica Therapeutics Stock (ASX:AGN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
A$104.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Argenica Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AGN Stock News Headlines

A New Way to Double Your Retirement Income?
Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boom. For retirees, that could mean a way to generate reliable monthly income—without the outdated 4% withdrawal rule, risky trading, or high-fee annuities. If you’re ready to stop worrying about money running out and start enjoying the freedom to cover expenses, treat loved ones, and live life on your terms, this may be exactly what you’ve been waiting for.tc pixel
ASX Penny Stock Highlights For May 2025
Argenica Therapeutics Ltd Ordinary Shares AGN
See More Headlines

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
Insurance
Current Symbol
ASX:AGN
CIK
N/A
Fax
N/A
Employees
22,300
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($0.06)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$5.48 million
Net Margins
-238.05%
Pretax Margin
N/A
Return on Equity
-60.20%
Return on Assets
-27.35%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.75
Quick Ratio
12.21

Sales & Book Value

Annual Sales
A$2.60 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
A$0.13 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
128,090,000
Free Float
N/A
Market Cap
A$104.40 million
Optionable
Not Optionable
Beta
0.79
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (ASX:AGN) was last updated on 8/26/2025 by MarketBeat.com Staff
From Our Partners